However, FICZ, an endogenous AHR ligand, did not exhibit the same efficacy, suggesting that activation with different classes of ligands may have different biological effects and that nontoxic AHR agonists may have the potential capacity to treat HSV-induced eye infections [23]. This evidence concerns the gene AHR and eye infection.